Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The DETECT Study - Discovery and Evaluation of Testing for Endometrial and Ovarian Cancer in Tampons: Tampon and Tissue Sampling to Evaluate Markers for Detection of Endometrial and Ovarian Cancer

NCT03538665 is registered in ClinicalTrials.gov with University of Alabama at Birmingham as lead sponsor.

NCT NCT03538665
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03538665 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The DETECT Study - Discovery and Evaluation of Testing for Endometrial and Ovarian Cancer in Tampons: Tampon and Tissue Sampling to Evaluate Markers for Detection of Endometrial and Ovarian Cancer
Lead sponsor
University of Alabama at Birmingham
Phase
Observational
Overall status
Recruiting
Start date
July 1, 2019
Completion date
August 31, 2027
Enrollment
1,700 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

complex atypical endometrial hyperplasia, endometrial cancer, endometrial cancer precursors, ovarian cancer